Perspective Therapeutics Inc (CATX)
1.58
-0.02
(-1.25%)
USD |
NYAM |
Apr 26, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Perspective Therapeutics Free Cash Flow: -37.98M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -37.98M |
September 30, 2023 | -30.74M |
June 30, 2023 | -23.40M |
March 31, 2023 | -16.22M |
September 30, 2022 | -7.691M |
June 30, 2022 | -7.976M |
March 31, 2022 | -6.213M |
December 31, 2021 | -5.479M |
September 30, 2021 | -4.905M |
June 30, 2021 | -3.218M |
March 31, 2021 | -2.858M |
December 31, 2020 | -3.05M |
September 30, 2020 | -3.614M |
June 30, 2020 | -3.914M |
March 31, 2020 | -4.117M |
December 31, 2019 | -4.677M |
September 30, 2019 | -4.518M |
June 30, 2019 | -5.493M |
March 31, 2019 | -5.971M |
December 31, 2018 | -5.666M |
September 30, 2018 | -6.06M |
June 30, 2018 | -6.049M |
March 31, 2018 | -5.964M |
December 31, 2017 | -6.342M |
September 30, 2017 | -6.476M |
Date | Value |
---|---|
June 30, 2017 | -6.261M |
March 31, 2017 | -6.232M |
December 31, 2016 | -5.674M |
September 30, 2016 | -4.763M |
June 30, 2016 | -4.376M |
March 31, 2016 | -3.625M |
December 31, 2015 | -3.820M |
September 30, 2015 | -3.633M |
June 30, 2015 | -3.673M |
March 31, 2015 | -3.989M |
December 31, 2014 | -3.320M |
September 30, 2014 | -3.521M |
June 30, 2014 | -3.265M |
March 31, 2014 | -3.047M |
December 31, 2013 | -3.296M |
September 30, 2013 | -3.020M |
June 30, 2013 | -3.069M |
March 31, 2013 | -2.933M |
December 31, 2012 | -3.028M |
September 30, 2012 | -2.931M |
June 30, 2012 | -2.543M |
March 31, 2012 | -2.556M |
December 31, 2011 | -2.297M |
September 30, 2011 | -2.492M |
June 30, 2011 | -2.576M |
Free Cash Flow Range, Past 5 Years
-37.98M
Minimum
Dec 2023
-2.858M
Maximum
Mar 2021
-9.782M
Average
-5.192M
Median
Free Cash Flow Benchmarks
Retractable Technologies Inc | 1.914M |
InfuSystems Holdings Inc | 0.106M |
Xtant Medical Holdings Inc | -10.97M |
Asensus Surgical Inc | -64.19M |
Catheter Precision Inc | -20.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -9.008M |
Cash from Investing (Quarterly) | -0.089M |
Cash from Financing (Quarterly) | 0.352M |
Free Cash Flow Per Share (Quarterly) | -0.0324 |
Free Cash Flow to Equity (Quarterly) | -9.085M |
Free Cash Flow to Firm (Quarterly) | -9.097M |
Free Cash Flow Yield | -8.99% |